BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24893962)

  • 1. Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion.
    Gaye A; Diop A; Shochet T; Winikoff B
    Int J Gynaecol Obstet; 2014 Sep; 126(3):223-6. PubMed ID: 24893962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual [corrected] misoprostol as first-line care for incomplete abortion in Burkina Faso.
    Blandine T; Ouattara AZ; Coral A; Hassane C; Clotaire H; Dao B; Lankoande J; Diop A; Blum J
    Int J Gynaecol Obstet; 2012 Nov; 119(2):166-9. PubMed ID: 22935621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting.
    Ngoc NT; Shochet T; Blum J; Hai PT; Dung DL; Nhan TT; Winikoff B
    BMC Pregnancy Childbirth; 2013 May; 13():118. PubMed ID: 23697561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries.
    Shochet T; Diop A; Gaye A; Nayama M; Sall AB; Bukola F; Blandine T; Abiola OM; Dao B; Olayinka O; Winikoff B
    BMC Pregnancy Childbirth; 2012 Nov; 12():127. PubMed ID: 23150927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating women's acceptability of treatment of incomplete second trimester abortion using misoprostol provided by midwives compared with physicians: a mixed methods study.
    Atuhairwe S; Hanson C; Atuyambe L; Byamugisha J; Tumwesigye NM; Ssenyonga R; Gemzell-Danielsson K
    BMC Womens Health; 2022 Nov; 22(1):434. PubMed ID: 36335344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria.
    Fawole AO; Diop A; Adeyanju AO; Aremu OT; Winikoff B
    Int J Gynaecol Obstet; 2012 Nov; 119(2):170-3. PubMed ID: 22935620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral misoprostol for the management of incomplete abortion in Ecuador.
    Montesinos R; Durocher J; León W; Arellano M; Peña M; Pinto E; Winikoff B
    Int J Gynaecol Obstet; 2011 Nov; 115(2):135-9. PubMed ID: 21872244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
    Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
    BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
    Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
    Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study between oral and sublingual 600 µg misoprostol for the treatment of incomplete abortion.
    Paritakul P; Phupong V
    J Obstet Gynaecol Res; 2010 Oct; 36(5):978-83. PubMed ID: 20846257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing misoprostol for the treatment of incomplete abortion in Nigeria.
    Dah T; Akiode A; Awah P; Fetters T; Okoh M; Ujah I; Oji E
    Afr J Reprod Health; 2011 Dec; 15(4):42-50. PubMed ID: 22571104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of incomplete abortion and miscarriage with misoprostol.
    Blum J; Winikoff B; Gemzell-Danielsson K; Ho PC; Schiavon R; Weeks A
    Int J Gynaecol Obstet; 2007 Dec; 99 Suppl 2():S186-9. PubMed ID: 17961569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals.
    Dabash R; Ramadan MC; Darwish E; Hassanein N; Blum J; Winikoff B
    Int J Gynaecol Obstet; 2010 Nov; 111(2):131-5. PubMed ID: 20801444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled study comparing 600 versus 1,200 microg oral misoprostol for medical management of incomplete abortion.
    Nguyen TN; Blum J; Durocher J; Quan TT; Winikoff B
    Contraception; 2005 Dec; 72(6):438-42. PubMed ID: 16307967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial.
    Klingberg-Allvin M; Cleeve A; Atuhairwe S; Tumwesigye NM; Faxelid E; Byamugisha J; Gemzell-Danielsson K
    Lancet; 2015 Jun; 385(9985):2392-8. PubMed ID: 25817472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya.
    Makenzius M; Oguttu M; Klingberg-Allvin M; Gemzell-Danielsson K; Odero TMA; Faxelid E
    BMJ Open; 2017 Oct; 7(10):e016157. PubMed ID: 29018067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACOG Committee Opinion No. 427: Misoprostol for postabortion care.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2009 Feb; 113(2 Pt 1):465-8. PubMed ID: 19155922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IS MISOPROSTOL A SUITABLE ALTERNATIVE TO THE SURGICAL EVACUATION OF INCOMPLETE ABORTION IN RURAL SOUTH-EASTERN NIGERIA?
    Chigbu B; Onwere S; Aluka C; Kamanu C; Ezenobi O
    East Afr Med J; 2012 May; 89(5):172-7. PubMed ID: 26875224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing misoprostol for treatment of incomplete abortion: A feasibility and acceptability study in secondary-level health facilities in Myanmar.
    Mary M; Tin KN; Maung TM; Maung HN; Ku SK; Winikoff B
    Sex Reprod Healthc; 2023 Jun; 36():100825. PubMed ID: 36842188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa.
    Dao B; Blum J; Thieba B; Raghavan S; Ouedraego M; Lankoande J; Winikoff B
    BJOG; 2007 Nov; 114(11):1368-75. PubMed ID: 17803715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.